Anika Therapeutics Inc
ANIK
NASDAQ
Biotechnology
$21.50
USD
+0.33 (+1.56%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $286.13M
Volume 124.9K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
SION | Sionna Therapeutics Inc | $2.31B | - | - | - | |
IRD | Opus Genetics Inc | $309.49M | - | -12.2% | - | |
MYGN | Myriad Genetics Inc | $307.03M | - | -3.2% | - | |
AVXL | Anavex Life Sciences Corp | $300.34M | - | - | - | |
FATE | Fate Therapeutics Inc | $293.73M | - | -52.6% | - | |
TRDA | Entrada Therapeutics Inc | $290.08M | - | -94.1% | - | |
ANIK | Anika Therapeutics Inc | $286.13M | - | -2.5% | - | |
ELDN | Eledon Pharmaceuticals Inc | $285.59M | - | - | - | |
SRZN | Surrozen Inc | $278.91M | - | -35.6% | - | |
ALXO | ALX Oncology Holdings Inc | $272.41M | - | - | - | |
ZSQR | Z Squared Inc (Delaware) | $219.83M | - | +2149.0% | - |
Top Peer by Growth
Z Squared Inc (Delaware)
+2149.0% YoY Revenue
Best 1-Year Return
Opus Genetics Inc
+238.2% Return